Brand: Health Concerns

Tablet or PillOn Market
Click to view full label

Net Contents

90 Tablet(s)

Serving Size

3 Tablet(s)

Servings Per Container

Not specified

Supplement Form

Tablet or Pill

Bar Code (UPC/SKU)

Not specified

Product Version

Not specified

Suggested Use

Suggested Use: Three tablets 2 to 3 times per day between meals.

Market Reference

$15.16 – $117.06· 18 listings
  • Astra 8 Health Concerns

    Health Concerns4.9(16)
    $69.90
  • Health Concerns Rehmannia 8

    citylets.net4.6(25)
    $15.16Lowest
  • Health Concerns Astra Garlic

    Pine Street Clinic5.0(7)
    $35.90
  • Astra Isatis Health Concerns

    Supplement First4.9(14)
    $31.90
  • Fusion Astra 8 60 Tablets

    amama
    $36.16
  • Astra 8 Capsules, 90 Capsules

    TheNatural.com5.0(23)
    $27.90
  • Astra Essence Health Concerns

    Nutriessential.com5.0(23)
    $26.91
  • Astra C Health Concerns

    Village Green Apothecary4.9(18)
    $22.43

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

  • Professional Supplement Center

    3.9 (72)

    Vitamin & supplements store

    5525 Palmer Crossing Cir, Sarasota, FL 34233

Research & Studies

  • Thymus ad astra, or spaceflight-induced thymic involution

    W Muramatsu, M Maryanovich, T Akiyama… - Frontiers in …, 2025 - frontiersin.org

    … health concern and impairing their performance (61–67). Additional evidence of adverse immunological manifestations occurring during either short- or long-duration spaceflight …

    20254 citations
  • Impact of the Astra Zeneca COVID‐19 vaccine on an emergency department

    J Deans, B Burns, W Portas, C Hannah… - Emergency Medicine …, 2025 - Wiley Online Library

    … Subsequently, on 8 April 2021 ATAGI released guidance advising individuals under the … healthcare system. The phenomenon of patients presenting to the EDs with AZ vaccine concern …

    20251 citations
  • Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population

    A Miners, A Phillips, N Kreif, A Rodger, A Speakman… - The lancet HIV, 2014 - thelancet.com

    … We merged two UK cross-sectional surveys: the ASTRA study, which recruited participants … only in ASTRA). Second, the possibility of endogeneity was a particular concern. That is, …

    2014436 citations
  • The phytoestrogen genistein induces thymic and immune changes: a human health concern?

    S Yellayi, A Naaz, MA Szewczykowski, T Sato… - Proceedings of the …, 2002 - pnas.org

    … rodents induces thymic atrophy and immune suppression (8, 9). Despite genistein's affinity for … We determined whether the anti-estrogen ICI 182,780 (Astra-Zeneca, Macclesfield, UK) …

    2002352 citations
  • Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study

    L Burch, C Smith, J Anderson, L Sherr, A Rodger… - J Int AIDS …, 2014 - Wiley Online Library

    … data from ASTRA, a crosssectional, questionnaire study of! 3000 individuals from 8 clinics in … This is of concern regarding their own health, as well as risk for sexual partners and …

    201424 citations
  • Assessing cost savings when unnecessary utilization of laboratory tests can be abolished

    P Winkel, BE Statland - American Journal of Clinical Pathology, 1984 - academic.oup.com

    … ready to be assayed by the analyst using either the ASTRA-8 or the RA-1000 system. The direct … We suggest that computer vendors be made aware of our concerns to audit laboratory …

    198425 citations

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2017-04-25. DSLD Label ID: 72690. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.